The Benefits of Group A Streptococcus NAAT
Labs that invested heavily in POC molecular tests during COVID-19 are well positioned to leverage this equipment toward GAS diagnostics
Labs that invested heavily in POC molecular tests during COVID-19 are well positioned to leverage this equipment toward GAS diagnostics
New policies aim to better protect data against increasing cyberattacks, but academics say the changes will limit critical research
How widespread is corruption in the lab—and what can be done to combat it?
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
The ALZpath DX assay is less invasive than other diagnostic tests, and may give patients diagnosed with Alzheimer’s more time to plan
The impending legislation that may determine Medicare lab fees from 2025 onward
Recent enforcement actions include convictions and guilty pleas for false claims-related allegations involving toxicology labs.
Formulating queries that are compliant, informative, and effective—even in tricky situations.
Program outlined in a recently introduced bill would test AI’s effectiveness in detecting suspect payments for diagnostic tests and DME.
How clinical laboratory professionals can advocate for legislative and regulatory improvements
Joyce Gresko, partner at Alston & Bird, discusses the latest on PAMA and what will likely need to happen for SALSA to pass in 2024.